Lucy Bhatt
MD
Clinical Trialist
👥Biography 个人简介
Lucy Bhatt designs and conducts early phase clinical trials of targeted therapies for prostate cancer with DNA damage repair alterations including CDK12 mutations. Her work evaluates how synthetic lethal strategies such as PARP inhibition and immune checkpoint blockade perform in CDK12 altered disease. She integrates genomic profiling into trial enrollment.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Lucy Bhatt 的研究动态
Follow Lucy Bhatt's research updates
留下邮箱，当我们发布与 Lucy Bhatt（University College London）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment